![John Crowley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Crowley
Vorstandsvorsitzender bei
Biotechnology Innovation Organization
Profil
John Francis Crowley ist Gründer von Amicus Therapeutics, Inc., Orexigen Therapeutics, Inc. und Novazyme Pharmaceuticals, Inc. und ist Chairman & Chief Executive Officer von Amicus Therapeutics, Inc. Herr Crowley ist außerdem im Vorstand von 6 weiteren Unternehmen. In der Vergangenheit war er Director-Business Strategy bei Bristol Myers Squibb Co, President & Chief Executive Officer bei Orexigen Therapeutics, Inc, President & Chief Executive Officer bei Novazyme Pharmaceuticals, Inc, Litigation Associate-Health Care Practice Group bei Bingham Summers Welsh & Spilman, Senior Vice President von Genzyme Therapeutics Ltd. und National Chairman bei Make-A-Wish Foundation of America. Er erhielt einen Undergraduate-Abschluss von der Georgetown University, einen Graduate-Abschluss von der University of Notre Dame The Law School und einen MBA von der Harvard Business School.
Aktive Positionen von John Crowley
| Unternehmen | Position | Beginn |
|---|---|---|
St. Peter's University Hospital
 St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | 23.11.2010 |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Präsident | - |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Global Genes
 Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Direktor/Vorstandsmitglied | - |
The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Vorstandsvorsitzender | 04.03.2024 |
Ehemalige bekannte Positionen von John Crowley
| Unternehmen | Position | Ende |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.08.2022 |
| ENTRADA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.12.2023 |
| INTELLIA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.12.2023 |
| ░░░░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Crowley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Scioderm, Inc.
Scioderm, Inc. BiotechnologyHealth Technology Engages in the development of innovative therapies for areas of high unmet need, including orphan products | Health Technology |
Bingham Summers Welsh & Spilman
 Bingham Summers Welsh & Spilman Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops methods for modifying recombinantly produced enzymes | Commercial Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of America
 Make-A-Wish Foundation of America Miscellaneous Commercial ServicesCommercial Services Operates as a charitable organization | Commercial Services |
St. Peter's University Hospital
St. Peter's University Hospital Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
The Wall Street Journal CEO Council | |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Notre Dame The Law School
 University of Notre Dame The Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Commercial Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
